This inventor holds 1 USPTO granted patent. Top assignee: Rare Partners Srl. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Daniele Simoni: Innovator in Hemoglobin Induction
Introduction
Daniele Simoni is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medicine, particularly in the treatment of beta-thalassemia and sickle cell disease. His innovative work focuses on the use of isoxazole derivatives to induce fetal hemoglobin synthesis.
Latest Patents
Daniele Simoni holds a patent titled "Isoxazole derivatives as inducers of fetal hemoglobin in erythroid precursor cells from beta-thalassemic patients." This invention refers to the use of isoxazole derivatives to prepare a medicament capable of inducing fetal hemoglobin (HbF) synthesis in patients suffering from beta-thalassemia and sickle cell disease. He has 1 patent to his name.
Career Highlights
Simoni is associated with Rare Partners Srl, where he continues to advance his research and development efforts. His work is crucial in addressing the medical needs of patients with hemoglobin disorders.
Collaborations
Daniele collaborates with esteemed colleagues, including Ilaria Lampronti and Roberto Gambari, who contribute to his research endeavors.
Conclusion
Daniele Simoni's innovative approach to inducing fetal hemoglobin synthesis represents a significant advancement in the treatment of hemoglobin disorders. His contributions are vital for improving the lives of patients affected by these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile